Acne is a disruption in the skin caused by different factors, including bacteria, hormones
and genetics. The pilosebaceous unit is comprised of the hair-growing follicle and the
sebaceous gland which releases sebum to the skin surface through the pore. There is a
normal population of bacteria called Propionibacterium Acnes in the skin, but when pores
become clogged the build-up of sebum and the enhanced cornification cause blackhead or
whitehead comedones to form within the pores. The anaerobic conditions in the comedones
stimulate the proliferation of P.Acnes which in turn induces inflammation. White blood cells
infiltrate the area and ensuing inflammation can lead to acneiform lesions called papules,
nodules or cysts. The goals of treatment for activeeruptive acne are: to reduce the bacteria
count of the acne-causing P.Acnes and to control the activity of the sebaceous glands to
reduce excess sebum production. The clinical improvements in the appearance of acne are
evidenced by reducing the size of individual acne lesions, reducing the frequency of acne
eruptions, and promoting faster healing times.Preventing future blockages or clogging of
pores can be facilitated through avariety of topical therapies including micro-dermabrasion,
light chemical peels, and an acne skin care regimen.Th AC applicator applicator uses a broad
spectrum of light and radio-frequency energies to target the sebaceous unit in the skin.
The short wavelengths in the blue light spectrum target the P.Acnes bacteria in the tubes of
the sebaceous glands. The photodynamic reaction between the blue light and the
photoporphyrins, which are an integral part of the bacterial membrane
(light- sensitive molecules), results in oxidation and free radical damage to the bacterial cell
membrane. P.Acnes are destroyed in this free radical environment, reducing bacterial count
and stopping the inflammatory process within the sebaceous gland. The red and infra-red
portions of the optical spectrum, as well as the radio-frequency energy, have a thermal drying
effect deeper in the sebaceous glands to produce and secrete less sebum. The addition of
radio-frequency in the AC application also offers the unique advantage of improving the
texture of acneiform skin (which is often left blotchy and rough after acne eruptions).
The AC procedure is a low risk treatment with no down-time, which can offer gradual and safe
improvements for patients with active papular-papulopustular acne.
The treatment sessions during the initial four weeks are aimed at gradually attacking the P.Acnes population in the sebaceous gland. The
clinical improvements, as a result of lowered bacterial count and consequential sebaceous gland normalization, may not be evident until
approximately half way through the series. Patients may notice improvement in acne lesions after two weeks or four treatments, however
there are patients that respond faster or more slowly than average. While the AC application can treat existing acne and also help to maintain
results, genetic and environmental factors may cause new acne break-outs. Further treatments may be performed as a maintenance program
for slight papular acne (once or twice a month) or another bolus of treatments to get severe outbreaks under control
(twice weekly for four weeks). A skin care regimen for acneic skin should be promoted, including but not limited to: oil-free sunscreen,
gentle washer/toner, oil and keratin regulation agents such as glycolic acid, AHA, retinoids, and other products that help prevent a plug formation
of epidermal keratin. Treatment for male patients in hair-bearing areas may result in damage to the follicles and subsequent loss of hair. Avoid
the beard area and other hair growing zones if the patient does not wish to have reduction or decreasing of the hair growth. If treatment is being
performed over hairy areas, ensure the hair is clipped or shaved prior to treatment. Residual erythema and/or pigmentary changes in the skin are
common sequelae after acne lesions heal. Such dyschromia can be addressed with SRA Plus treatments to improve the vascular and
melanin-based irregularity. The AC applicator provides some improvement to rough acneic skin. Acne scarring can be improved with the
Sublative RF treatments, which may induce collagen renewal in areas of depressed scarring and dermal fissures.
Porphyria, and Epilepsy.
- Pacemaker or internal defibrillator.
- Superficial metal or other implants in the treatment area.
- Current or history of skin cancer, or current condition of any other type of cancer, or pre-malignant moles.
- History of any kind of cancer.
- Severe concurrent conditions, such as cardiac disorders.
- Pregnancy or nursing.
- Impaired immune system due to immunosuppressive diseases such as AIDS and HIV, or use of immunosuppressive medications.
- Diseases which may be stimulated by light at the wavelengths used, such as history of Systemic Lupus Erythematosus,
following a prophylactic regimen.
- Patients with history of diseases stimulated by heat, such as recurrent Herpes Simplex in the treatment area, may be treated only
used, such as Isotretinoin
- Poorly controlled endocrine disorders, such as Diabetes.
- Any active condition in the treatment area, such as sores, Psoriasis, eczema and rash.
- History of skin disorders, keloids, abnormal wound healing, as well as very dry and fragile skin.
- History of bleeding coagulopathies, or use of anticoagulants with the exception of preventive low dose aspirin medication.
- Use of medications, herbs, food supplements, and vitamins known to induce photosensitivity to light exposure at the wavelengths
- (Accutane) within the last six months, Tetracyclines, or St. John's Wort within the last two weeks.
- Facial laser resurfacing and deep chemical peeling within the last three months, if face is treated.
- Any surgical procedure in the treatment area within the last three months or before complete healing.
- Treating over tattoo or permanent makeup.
- Excessively tanned skin from sun, tanning beds or tanning creams within the last two weeks.
- As per the practitioner's discretion, refrain from treating any condition which might make it unsafe for the patient.